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Abstract.  The aim of the study is to assess the clinical spectrum of 
immunorestitution disease (IRD) in hospitalised patients over a 12-month period.  In 
9 of 18 patients who presented with clinical deterioration during reduction or 
cessation of immunosuppressants (n=6) or bone marrow engraftment (n=3), IRD 
cases included scabies infestation (n=1), gastric strongyloidiasis (n=1), hepatosplenic 
candidiasis (n=1), methicillin-resistant Staphylococcus aureus abscess formation 
(n=2), polyomavirus-related hemorrhagic cystitis (n=3), and influenza A pneumonitis 
(n=1).  Immunopathological damage during withdrawal of immunosuppression is an 
incidental way to uncover an asymptomatic infectious disease.  Serial monitoring of 
hematological and clinical profiles are essential in making a diagnosis of IRD.    
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Introduction 
The initial concept of immunorestitution disease (IRD) was enlightened by the 
observation of the onset of symptomatic expression or paradoxical deterioration of 
pre-existing infectious diseases, including cytomegalovirus retinitis, pulmonary or 
extrapulmonary tuberculosis, atypical mycobacterial lymphadenitis, and cryptococcal 
infection, in HIV-positive patients with a recovery of CD4+ lymphocyte counts after 
initiation of highly active antiretroviral therapy (HAART) [1].  However, the 
encompassing concept of IRD involving innate and adaptive immunity was 
subsequently formulated with the observation of a similar phenomenon in non-HIV 
immunosuppressed patients with opportunistic infections after dosage reduction or 
withdrawal of steroid, recovery of absolute neutrophil count (ANC) from cytotoxic 
therapy, or engraftment after bone marrow transplantation (BMT) [2].  Despite these 
reports, the true incidence and the clinical spectrum of IRD in daily practice have not 
been documented.  The unawareness of clinicians about this emerging disease entity, 
the nonspecific clinical signs and symptoms, and the lack of a standard diagnostic 
laboratory test are all factors that hinder the understanding of this disease.  Therefore, 
a prospective study was conducted to evaluate the extent to which IRDs are 
encountered in our inpatient consultative service.  
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Materials and Methods 
Data were collected prospectively over a 12-month period (January 1999 - December 
1999) on patients referred for infectious disease (ID) consultation in a tertiary hospital 
(Queen Mary Hospital, Hong Kong, a 1,350-bed teaching hospital).  For the purpose 
of this study, patients who had received immunosuppressive therapy (systemic 
steroid, cytotoxic agents, or combination of steroid and cytotoxic agents) or 
undergone BMT (conditioning regimen including cytotoxic and/or total body 
irradiation), resulting in an ANC of less than 500/µl or an absolute lymphocyte count 
(ALC) of less than 1500/µl were defined as immunosuppressed hosts.  IRD is defined 
as an acute symptomatic illness or paradoxical deterioration of a (presumably) pre-
existing infection, which is temporally related to the recovery of the immune system 
and which is due to immunopathological damage associated with one of the 
following: (i) the reversal of immunosuppressive processes such as withdrawal of 
steroid, (ii) recovery of the ANC from chemotherapy, or (iii) engraftment after BMT.  
The pre-existing microbial infection could be either asymptomatic or mildly 
symptomatic. 
The handling procedure for consultations has been described previously [3, 4].  
Besides detailed history and physical examination, case notes review, the dosing 
regimen of immunosuppressive therapy, and the exact timing of dosage reduction or 
withdrawal of immunosuppressants were noted in immunosuppressed patients.  The 
time interval between reduction or withdrawal of immunosuppressive therapy, 
recovery of ANC after cytotoxic agents, or engraftment after BMT and onset of 
clinical symptoms of IRD were recorded.  
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Results and Discussion 
In this prospective study, there were 2,225 inpatient ID consultations over the study 
period, of which 280 (12.6%) patients with median age of 45, ranged 1-83, were 
receiving immunosuppressive therapy.   Eighteen (6.4%) patients had onset of or 
worsening of clinical symptoms and signs when the doses of immunosuppressants 
were being reduced or the drugs withdrawn.  IRD was documented in 9 (50%) of 
these patients. The clinical details of these cases are listed in table 1.  
Case 1 was a 12-year-old boy presented with pruritic lesions over the external 
genitalia 4 days after the engraftment of neutrophil following allogeneic BMT for his 
dyskeratosis congenita.  He developed neutropenic fever and was put on empirical 
intravenous ceftazidime and amikacin.  He engrafted on day 13 with a total leukocyte 
count of 1,630/µl, ANC 880/µl, ALC 390/µl and AMC 260/µl.  During the 
postengraftment period, his ANC progressively increased from 880/µl to 4,450/µl and 
AMC from 260/µl to 1,410/µl on day 13 to 16 respectively.  On day 17, while the 
ANC was 2,140/µl and AMC was 1,020/µl, he was noted to have multiple pruritic 
erythematous nodules over the penis and scrotum.  Skin biopsy on day 21 
demonstrated nonspecific histiocytic aggregation and lymphoplasmacytic infiltration 
in dermal and epidermal layers but there was no apoptotic bodies suggestive of 
cutaneous GVHD.  Wet mount of the skin scraping confirmed the presence of 
Sarcoptes scabiei.  A diagnosis of postengraftment scabies was made.  He was treated 
with a standard regimen of topical benzyl benzoate for 2 days with satisfactory 
clinical improvement.  Contact tracing of the family members revealed that his 
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younger brother, who used to sleep with the patient, also suffered from the same 
disease three weeks before the patient underwent BMT.   
Case 2 was a 42-year-old woman with a history of lupus nephritis receiving long-term 
steroid and azathioprine, admitted for surgical management of necrotizing fasciitis of 
her right lower limb.  She improved after radical surgical debridement and a 
combination of intravenous antibiotic therapy including amoxicillin-clavulanate and 
ofloxacin.  During the convalescent phase, the dose of prednisolone was reduced from 
60 mg qd to 15 mg qd over 29 days while the AEC increased from 30/µl to 1,100/µl 
and ALC increased from 560/µl to 1,800/µl respectively.  While the AEC and ALC 
levels were highest, she developed severe epigastric, cramping abdominal pain and 
diarrhea.  Upper endoscopy showed evidence of antral gastritis and duodenitis.  
Antral biopsy demonstrated multiple Strongyloides larvae in the gastric mucosa with 
inflammatory and eosinophilic infiltration.  IRD due to pre-existing gastric 
strongyloidiasis upon withdrawal of steroid was diagnosed and she was treated with 
oral albendazole 400 mg qd for 7 days.     
Case 7 was a 39-year-old man receiving high dose cyclophosphamide (120 mg/kg) 
and total body irradiation (12 Gy) as preconditioning therapy for autologous BMT for 
diffuse large cell lymphoma (stage 1A).  He had an uneventful course during the pre-
engraftment phase.  Surveillance cultures including surface swabs, urine culture, stool 
culture, and blood culture were taken on day 0, 7, 14 and weekly onwards for 
microbiological examination.  Asymptomatic shedding of polyomavirus was detected 
in the urine on days 14 and 21 when the corresponding ALC were 0 and 300/µl 
respectively. Electron microscopy (EM) showed the presence of numerous non-
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enveloped virus particles of 40 nm in diameter inside the intranuclear inclusion 
bearing cells.  Cytological examination of urine demonstrated scattered, large atypical 
cells, which were round and spindle-shaped with a high nuclear / cytoplasmic ratio in 
both Sterheimer-Malbin staining and Papanicolaou staining.  The bone marrow 
engrafted on day 24, when the total leukocyte count was 2,100/µl, ANC 600/µl and 
ALC 1,100/µl.  On the same day, he developed symptomatic hemorrhage cystitis with 
worsening of dysuria and increasing hematuria.  Repeated EM examination of urine 
on day 28 was negative for polyomavirus.  He was treated with IVIG for 3 days and 
the symptoms subsided on day 34 while the ALC dropped to 400/µl. 
As shown in the illustrative cases, besides the worsening of underlying diseases, 
development of antimicrobial resistance, and other noninfectious complications, IRD 
should be considered as an important differential diagnosis in this particular group of 
patients.  
A broad spectrum of microorganisms have been identified in patients with IRD, 
including parasites, fungi, mycobacteria, bacteria and viruses.  Systemic 
mycobacterial and fungal infection in the setting of IRD had been discussed in detail 
in our previous study [2].  The ectoparasite, Sarcoptes scabiei, is first documented as 
a manifestation of IRD in the present study.  Similar observations to those in our 
patient have previously been reported in a 4-year-old boy undergoing BMT for acute 
lymphoblastic leukemia [5].  However, the authors did not report the case from the 
perspective of IRD and the lack of serial hematological profiles made documentation 
of IRD impossible.  A severe form of scabies, called Norwegian or crusted scabies, 
has been reported in solid organ transplant recipients and AIDS patients [6, 7].  It is 
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characterized by widely distributed psoriasis-like hyperkeratotic crusted nodules and 
plaques.  Although the number of viable mites found on a single patient could be 
thousands or even millions, there is far less pruritis and frank inflammation is often 
lacking.  The clinical manifestations of scabies depend on the host immunity, as 
supported by a previous study in which skin was injected intradermally with 
Sarcoptes extracts in an immunocompetent host.  Mononuclear cellular infiltration 
was detected by serial histological sectioning [8].  
Human strongyloidiasis was also associated with IRD in this study.  Strongyloides 
infection is normally checked by cell-mediated immunity with predominantly T-
helper type two response resulting in eosinophilia.  Overwhelming infection in terms 
of massive invasion of the gastrointestinal tract and pulmonary tissue may occur in 
patients with defective T lymphocyte function [9, 10].  Our patient survived the 
infection during the immunosuppressive phase with few symptoms but developed 
IRD manifesting as abdominal pain and diarrhea after reduction of the dose of steroid.  
Recovery of the immune system was evidenced by progressive rise in ALC and AEC.  
The occurrence of immunopathological damage during withdrawal of 
immunosuppressive therapy or bone marrow engraftment, as exemplified in parasitic 
infestations, is an incidental way to uncover an undiagnosed asymptomatic infectious 
disease in patients with underlying disease which require immunosuppression. 
Pyogenic bacterial infections are also associated with IRD.  Previously, we 
hypothesized that IRD would be confined to patients infected by slow growing 
pathogens of low virulence.  In actual fact, IRD can also be observed in pyogenic 
bacterial infection in tissues where antibiotic penetration is problematic.  Patient 5 
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developed pyomyositis following an episode of catheter-related MRSA bacteremia.  
We postulate that the occurrence of pyomyositis was secondary to the metastatic 
deposit of the organism to a microhematoma inside the calf muscle.  The 
microhematoma provided an environment for bacterial multiplication and protection 
from antibiotic killing.  During the neutropenic phase, he had nonspecific cramping in 
the affected area.  Subsequently, during immunorestitution, erythema and swelling 
developed, and evolved to a firm, hard or woody mass.  Later the infiltration of 
neutrophils produced an area of fluctuance and aspiration at this stage yielded 
purulent material.   
As for viral infection, polyomavirus-related hemorrhagic cystitis in BMT recipients 
after reduction of steroid in the treatment of GVHD or after engraftment constituted 
33% of cases in the present study.  Reactivation of latent polyomavirus due to 
impairment of cell mediated immunity has been demonstrated as one of the 
etiological factors for hemorrhagic cystitis in seropositive patients undergoing BMT.  
The occurrence of disease correlated with viruria and the shedding of virus could 
precede or coincide with the onset of cystitis [11, 12].  However, the incidence of 
hemorrhagic cystitis following withdrawal of immunosuppressants or bone marrow 
engraftment has not been investigated in previous studies [11, 12].  In patient 7, we 
clearly demonstrated asymptomatic shedding of polyomavirus during the pre-
engraftment or immunosuppressive phase.  The patients developed symptomatic 
hemorrhagic cystitis after recovery of the immune system as evidenced by the 
concomitant increase in ALC either by marrow engraftment or rapid dosage reduction 
of steroid.  Therefore, besides cytolytic damage during immunosuppression, the 
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immunopathological manifestation of polyomavirus-related hemorrhagic cystitis 
should also be considered as an IRD in certain setting.  However, the bleeding 
diathesis limited our assessment of the histological changes in the urinary bladder 
during immunosuppression and IRD.  In renal transplant recipients, cytopathic 
changes with nuclear enlargement, irregularity of nuclear contour, and clumping and 
smudging of chromatin pattern are the predominant lesions of polyomavirus infection 
during immunosuppression.  Extensive interstitial inflammation by mononuclear cells 
and plasma cells may occur in the phase of immunorestitution resulting in 
immunopathological damage [13, 14].  This may explain why polyomavirus is not 
detected in urine during symptomatic cystitis.  The use of IVIG therapy as an 
effective immunomodulating agent to control the overwhelming inflammatory 
response during immunorestitution was anecdotally associated with a decrease in the 
duration of symptoms by 7 to 10 days in our patients.   
In view of the wide spectrum of pathogens involving different organ systems, ID 
specialists should be vigilant in considering this new diagnostic entity.  In the 
assessment of any immunosuppressed patient with suspected infection, careful review 
of the regimen of immunosuppressive therapy, close monitoring of serial 
hematological profiles, and detailed analysis of signs and symptoms before and 
during immune recovery are crucial in diagnosing IRD.  New information will be 
generated as more cases of IRD are identified.  With a better understanding of this 
disease, prophylactic, preemptive and therapeutic regimens for IRD could be 
established.  
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 Table 1.  Immunorestitution disease (IRD) encountered in infectious disease 
consultation 
Case 
no. 
Sex / 
age 
Underlying 
diseases / IS 
therapy 
Infecting 
organisms/ 
sites/ details 
of recovery 
of immune 
system 
Duration 
between 
recovery 
of 
immune 
system 
and onset 
of IRD 
 
Cell 
counts 
before 
IRD 
(/µlL) 
Cell 
counts 
during 
IRD 
(/µlL) 
Symptoms 
and signs of 
IRD 
Treatment 
of IRD in 
addition to 
anti-
microbial 
therapy 
1 M/12 dyskeratosis 
congenita; 
allogeneic 
BMT 
Sarcoptes 
scabiei 
involving 
external 
genitalia after 
engraftment 
of marrow 
 
4 days AMC 
260; 
ANC 
<500 
AMC 
1020; 
ANC 
2140 
multiple 
pruritic 
erythematous 
nodules in 
penile and 
scrotum 
Nil 
2 F/42 SLE; on high 
dose steroid 
Strongyloides 
involving 
stomach after 
dosage 
reduction of 
prednisolone 
60mg qd to 
15mg qd over 
29 days  
 
29 days AEC 
30; 
ALC 
560 
AEC 
1100; 
ALC 
1800 
abdominal 
pain and 
diarrhoea; 
antral biopsy 
showed 
numerous 
Strongyloides 
Nil 
3 F/22 ALL; 
consolidation 
chemotherapy 
HSC after 
recovery of 
ANC 
20 days ANC 
<500 
ANC 
10600 
recurrent 
fever; right 
upper 
quadrant pain 
and increasing 
ALP 
 
Nil 
4 M/38 AML; 
induction 
chemotherapy 
MRSA 
abscess of 
buccal 
mucosa after 
recovery of 
ANCa 
 
3 days ANC 
100 
ANC 
700 
left facial 
swelling and 
tenderness 
Nil 
5 M/38 AML; 
consolidation 
chemotherapy 
MRSA 
pyomyositis 
of both calf 
after recovery 
of ANCa 
 
 
3 days ANC 
<500 
ANC 
1700 
severe calf 
tenderness 
with abscess 
formation 
Nil 
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6 M/31 CML; 
allogeneic 
BMT; high 
dose steroid 
for graft-
versus-host-
disease 
polyomavirus
-related HC 
at day 94 
after dosage 
reduction of 
prednisolone 
from 60mg 
qd to 30mg 
qd over 8 
days  
 
8 days ALC 
400 
ALC 
1010 
dysuria and 
hematuria 
IVIG 
7 M/39 NHL; 
autologous 
BMT 
polyomavirus
-related HC 
at day 24 
after 
engraftment 
of marrow 
 
0 day ALC 
300 
ALC 
1100 
dysuria and 
hematuria 
IVIG 
8 F/8 beta- 
thalassemia / 
hemoglobin E  
transfusion 
dependent 
syndrome; 
allogeneic 
BMT; high 
dose steroid 
for graft-
versus-host 
disease 
 
Polyomavirus
-related HC 
at day 71 
after dosage 
reduction of 
methyl-
prednisolone 
from 100mg 
qd to 30mg 
qd over 20 
days  
 
20 days ALC 
70 
ALC 
600 
dysuria and 
hematuria  
Nil 
9 M/39 NHL; 
autologous 
BMT 
influenza A 
(H3N2) 
pneumonitis 
after 
engraftment 
of marrowb 
 
0 day ALC 
100 
ALC 
1100 
acute onset of 
shortness of 
breath; CXR 
showed 
extensive 
infiltrative 
lesions 
 
IVIG 
a MRSA bacteremia was documented before the recovery of ANC 
b Influenza A (H3N2) was documented in nasopharyngeal aspirates by direct antigen detection and viral 
culture before bone marrow engraftment   
 
AEC, absolute eosinophil count; ALC, absolute lymphocyte count; ALL, acute lymphoblastic leukemia; 
ALP, alkaline phosphatase; AMC, absolute monocyte count; AML, acute myeloid leukemia; ANC, 
absolute neutrophil count; BMT = bone marrow transplantation; CML = chronic myeloid leukemia; CXR = 
chest radiography; HC, hemorrhagic cystitis; HSC, hepatosplenic candidiasis; IRD, immunorestitution 
disease; IS, immunosuppressive; IVIG, intravenous immunoglobulin; MRSA, methicillin-resistant 
Staphylococcus aureus; NHL, non-Hodgkin lymphoma; SLE, systemic lupus erythematosus.   
 
 
